Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AP611074 5% Gel for Anogenital Warts
NCT01532102Phase 2Completed
- Sponsor
- Anaconda Pharma
- Start
- Feb 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of teslexivir in condylomata acuminata, sponsored by Anaconda Pharma. Started Feb 2012; status: completed.
02
Drugs
teslexivir
03
Conditions
condylomata acuminata
Beyond the preview
Go deeper on NCT01532102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01532102.